223 related articles for article (PubMed ID: 18606714)
21. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
22. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale.
Earing MG; Cabalka AK; Seward JB; Bruce CJ; Reeder GS; Hagler DJ
Mayo Clin Proc; 2004 Jan; 79(1):24-34. PubMed ID: 14708945
[TBL] [Abstract][Full Text] [Related]
23. Patent foramen ovale and paradoxical thromboembolism. Which treatment is the most appropriate?
Masetti F; Borra P; Maviglia S
Int J Cardiol; 2016 Mar; 207():370-1. PubMed ID: 26820371
[No Abstract] [Full Text] [Related]
24. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
[TBL] [Abstract][Full Text] [Related]
25. An aneurysmal interatrial septum with a patent foramen ovale and multiple fenestrations closed by a single occluder device.
Hajsadeghi S; Chitsazan M; Namazi M; Chitsazan M
Acta Med Iran; 2012; 50(10):713-6. PubMed ID: 23275290
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of trans-oesophageal echocardiography using intracardiac echography probe in guiding patent foramen ovale percutaneous closure.
Mitchell-Heggs L; Lim P; Bensaid A; Kloeckner M; Monin JL; Castanie JB; Hosseini H; Nahum J; Teiger E; Dubois-Randé JL; Gueret P
Eur J Echocardiogr; 2010 Jun; 11(5):394-400. PubMed ID: 20042422
[TBL] [Abstract][Full Text] [Related]
27. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.
Mas JL; Arquizan C; Lamy C; Zuber M; Cabanes L; Derumeaux G; Coste J;
N Engl J Med; 2001 Dec; 345(24):1740-6. PubMed ID: 11742048
[TBL] [Abstract][Full Text] [Related]
28. [Cryptogenic stroke and patent foramen ovale].
Windecker S; Nedeltchev K; Wahl A; Meier B
Ther Umsch; 2003 Sep; 60(9):553-61. PubMed ID: 14579624
[TBL] [Abstract][Full Text] [Related]
29. Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.
Rigatelli G; Dell'Avvocata F; Giordan M; Ronco F; Braggion G; Schenal N; Aggio S; Cardaioli P
J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):91-5. PubMed ID: 19829139
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis.
Stortecky S; da Costa BR; Mattle HP; Carroll J; Hornung M; Sievert H; Trelle S; Windecker S; Meier B; Jüni P
Eur Heart J; 2015 Jan; 36(2):120-8. PubMed ID: 25112661
[TBL] [Abstract][Full Text] [Related]
31. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N
Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613
[TBL] [Abstract][Full Text] [Related]
32. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
Majunke N; Wallenborn J; Wunderlich N; Sievert H
Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
[TBL] [Abstract][Full Text] [Related]
33. Ischaemic stroke with patent foramen ovale.
Jusufovic M; Thomassen L; Skjelland M
Tidsskr Nor Laegeforen; 2014 Jan; 134(2):180-4. PubMed ID: 24477152
[TBL] [Abstract][Full Text] [Related]
34. [Therapy changes after stroke in patients with open foramen ovale? : Patent Foramen Ovale Closure or Anticoagulants versus Antiplatelet Therapy to Prevent Stroke Recurrence Trial (CLOSE), Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT), and Carotid Revascularization Endarterectomy versus Stenting Trial (REDUCE)].
Bauer A; Nitschmann S
Internist (Berl); 2018 Feb; 59(2):213-216. PubMed ID: 29322216
[No Abstract] [Full Text] [Related]
35. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
[TBL] [Abstract][Full Text] [Related]
36. [Device thrombosis during the percutaneous closure of a patent foramen ovale].
Lezcano EJ; Ruiz JR; Lacambra I
Rev Esp Cardiol; 2011 Jun; 64(6):540-1. PubMed ID: 21414709
[No Abstract] [Full Text] [Related]
37. Transcathether occlusion of interatrial communications: postprocedural transoesophageal echocardiography allows timely detection and treatment of intracardiac thrombus formation.
Pelliccia F; Cianfrocca C; Pasceri V; Granatelli A; Speciale G; Roncella A; Turturo M; Richichi G; Pristipino C
Eur J Echocardiogr; 2009 May; 10(3):439-41. PubMed ID: 19036748
[TBL] [Abstract][Full Text] [Related]
38. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy.
Homma S; Sacco RL; Di Tullio MR; Sciacca RR; Mohr JP
J Am Coll Cardiol; 2003 Sep; 42(6):1066-72. PubMed ID: 13678932
[TBL] [Abstract][Full Text] [Related]
39. Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke.
Ghosh S; Ghosh AK; Ghosh SK
Postgrad Med J; 2007 Mar; 83(977):173-7. PubMed ID: 17344571
[TBL] [Abstract][Full Text] [Related]
40. Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale.
Zajarias A; Thanigaraj S; Lasala J; Perez J
J Invasive Cardiol; 2006 Nov; 18(11):533-7. PubMed ID: 17090816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
